Geode Capital Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Geode Capital Management’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-373,123	Closed	-$22.3M	–	4197
2020 Q2	$22.3M	Buy	373,123 +73,336	+24%	+$4.53M	﹤0.01%	1438
2020 Q1	$17.8M	Buy	299,787 +29,001	+11%	+$1.69M	﹤0.01%	1381
2019 Q4	$14.8M	Buy	270,786 +123,977	+84%	+$4.63M	﹤0.01%	1745
2019 Q3	$4.14M	Buy	146,809 +2,803	+2%	+$103K	﹤0.01%	2493
2019 Q2	$4.78M	Buy	144,006 +27,000	+23%	+$843K	﹤0.01%	2424
2019 Q1	$3.98M	Buy	117,006 +5,424	+5%	+$173K	﹤0.01%	2464
2018 Q4	$3.06M	Buy	+111,582	New	+$2.88M	﹤0.01%	2520

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Geode Capital Management's PRNB Position: Q3 2020 in Review

Geode Capital Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 373,123 shares — an estimated $22.3M sold.

Geode Capital Management first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $22.3M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Geode Capital Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Geode Capital Management sold 373,123 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $22.3M.
Geode Capital Management first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Geode Capital Management's Principia Biopharma Inc. Common Stock position peaked at $22.3M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Geode Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.